Andrew R. Conery

2.7k citations
16 papers · 1.9k indexed · 2 hit papers · h-index 11
Topics
Protein Degradation and Inhibitors (8 papers)Multiple Myeloma Research and Treatments (6 papers)Histone Deacetylase Inhibitors Research (5 papers)

In The Last Decade

Andrew R. Conery

15 papers receiving 1.9k citations

Hit Papers

Targeting MYC dependence in cancer by inhibiting BET brom...201120262016202120112019250500750

Peers

Andrew R. Conery
Comparison fields: 5 of 80
  • Molecular Biology 1.7k
  • Hematology 508
  • Oncology 421
  • Cancer Research 125
  • Pathology and Forensic Medicine 110
Replace Galinos Fanourakis with:
Galinos Fanourakis Greece
Yoko Ueno Japan
Karène Mahtouk France
Silvia Monestiroli Italy
Catherine Frelin Canada
Andrew G. Muntean United States
William Senapedis United States
Bradley W. Blaser United States
Maciej Kmieciak United States
Luc Van Rompaey Belgium
Andrew R. Conery relative to Galinos Fanourakis Greece Galinos Fanourakis's profile →
Citations per field
00.5×6.4×
Galinos Fanourakis · 1×
Citations per year

Countries citing papers authored by Andrew R. Conery

Since Specialization
Citations

This map shows the geographic impact of Andrew R. Conery's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Andrew R. Conery with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Andrew R. Conery more than expected).

Fields of papers citing papers by Andrew R. Conery

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Andrew R. Conery. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Andrew R. Conery. The network helps show where Andrew R. Conery may publish in the future.

Co-authorship network of co-authors of Andrew R. Conery

This figure shows the co-authorship network connecting the top 25 collaborators of Andrew R. Conery. A scholar is included among the top collaborators of Andrew R. Conery based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Andrew R. Conery. Andrew R. Conery is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

16 of 16 papers shown
#WorkIndexed citations
1 10
2 26
3 1
4
Bromodomains: a new target class for drug developmentbreakdown →
320
5 1
6 2
7 23
8 84
9 0
10 40
11
Targeting MYC dependence in cancer by inhibiting BET bromodomainsbreakdown →
876
12 97
13 15
14 29
15 22
16 338

About Andrew R. Conery

Andrew R. Conery is a scholar working on Hematology, Molecular Biology and Cancer Research, having authored 16 papers that have together received 1.9k indexed citations. Recurring topics across this work include Protein Degradation and Inhibitors (8 papers), Multiple Myeloma Research and Treatments (6 papers) and Histone Deacetylase Inhibitors Research (5 papers). The work is most often cited by research in Hematology (508 citations), Molecular Biology (1.7k citations) and Oncology (421 citations). Andrew R. Conery has collaborated with scholars based in United States, United Kingdom and China. Frequent co-authors include Robert J. Sims, Jennifer A. Mertz, Barbara M. Bryant, Péter Sandy, Louise Bergeron, Srividya Balasubramanian, Deanna A. Mele, Andrea G. Cochran, E. Aubrey Thompson and Tien C. Ko. Their work appears in journals such as Proceedings of the National Academy of Sciences, Genes & Development and PLoS ONE.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026